Status: current, Defined. Date: 31-May 2020. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 4375451000168111 | Zirabev (bevacizumab 100 mg / 4 mL) injection, 4 mL vial (trade product unit of use) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 4375461000168113 | Zirabev 100 mg/4 mL injection, 4 mL vial | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Zirabev 100 mg/4 mL injection, 4 mL vial | Is a | Zirabev | true | Inferred relationship | Some | ||
| Zirabev 100 mg/4 mL injection, 4 mL vial | Is a | trade product unit of use | true | Inferred relationship | Some | ||
| Zirabev 100 mg/4 mL injection, 4 mL vial | Is a | bevacizumab 100 mg / 4 mL injection, 4 mL vial (medicinal product unit of use) | true | Inferred relationship | Some | ||
| Zirabev 100 mg/4 mL injection, 4 mL vial | has manufactured dose form | injection | true | Inferred relationship | Some | ||
| Zirabev 100 mg/4 mL injection, 4 mL vial | has Australian BoSS | bevacizumab | true | Inferred relationship | Some | 1255719240 | |
| Zirabev 100 mg/4 mL injection, 4 mL vial | has intended active ingredient | bevacizumab | true | Inferred relationship | Some | 1255719240 | |
| Zirabev 100 mg/4 mL injection, 4 mL vial | has unit of use | vial | true | Inferred relationship | Some | 1132000391 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Zirabev 100 mg/4 mL injection, 4 mL vial | has TPUU | True | Zirabev 100 mg/4 mL injection, 4 mL vial | Inferred relationship | Some | 1320973000 |
| Zirabev 100 mg/4 mL injection, 4 mL vial | has TPUU | True | Zirabev 100 mg/4 mL injection, 4 mL vial | Inferred relationship | Some | 1258973174 |
Reference Sets
Trade product unit of use reference set
FHIR